SCHEMBL9604420

SCHEMBL9604420

Cc1ccc2c(nnn2CC2CC2)c1I

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 14/20 0.57
TDO2 P48775 3/20 0.39
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9926811 0.82 GRM2 (0.61) GRM2TDO2KDM4E
SCHEMBL9604229 0.82 GRM2 (0.61) GRM2TDO2
SCHEMBL8511766 0.82 GRM2 (0.54) GRM2TDO2
SCHEMBL9604350 0.79 GRM2 (0.64) GRM2TDO2L3MBTL1
SCHEMBL9605391 0.77 GRM2 (0.51) GRM2TDO2
SCHEMBL21713352 0.77 GRM2 (0.65) GRM2TDO2
SCHEMBL13726598 0.77 GRM2 (0.61) GRM2TDO2
SCHEMBL8512914 0.76 GRM2 (0.50) GRM2TDO2
SCHEMBL21713779 0.73 GRM2 (0.50) GRM2TDO2ALDH1A1LMNAL3MBTL1
SCHEMBL3474857 0.72 GRM2 (0.55) GRM2TDO2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139576-B2 Aminomethyl biaryl benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-09-22 US disclosed
US-8975286-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2015-03-10 US disclosed
US-8785482-B2 Cyclohexene benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8785481-B2 Ether benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-22 US disclosed
US-8772276-B2 Alkyne benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-08 US disclosed
US-20140088150-A1 CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-27 US disclosed
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-27 US disclosed
US-20140088151-A1 ALHYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. 2014-03-27 US disclosed
US-20140066443-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-06 US disclosed
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-06-14 US disclosed
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088150-A1 CYCLOHEXENE BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 GRM2 1/4885TDO2 1280/4885ALDH1A1 3085/4885
US-20120149677-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 GRM2 1/4885TDO2 1671/4885ALDH1A1 3327/4885
US-20120135977-A1 ETHER BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRIK2 GRM2 1/4885TDO2 1671/4885ALDH1A1 3327/4885
US-20140066443-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES GRM2, GRM3, GRIN2C GRM2 1/4885TDO2 1154/4885ALDH1A1 2342/4885
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRM3 GRM2 1/4885TDO2 1624/4885ALDH1A1 1808/4885
US-20140088151-A1 ALHYDROXYMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRM3 GRM2 1/4885TDO2 1090/4885ALDH1A1 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.